Join our three-member panel weighing in on the difficulties, pros, and cons of the proposed waiver of COVID-19 patents for drugs and vaccines under IP provisions of the TRIPS Agreement submitted to the WTO (World Trade Organization).
Are you a current law student and looking to register for one of our programs? Learn about the D.C. Bar Law Student Community and attend most individual programs at a discounted rate. Find out more here.
Sponsored by: Patent Committee of the D.C. Bar Intellectual Property Law Community Related Community of Interest: D.C. Bar Health Law Community; D.C. Bar Law Student Community
Dina Blikshteyn, J.D., Counsel, Intellectual Property Group, Haynes Boone
Justin D. Pine, J.D., Senior Director, International Affairs – Global IP and Data Policy, Biotechnology Innovation Organization (BIO)
Kevin Schubert, J.D., Litigator and Inter Partes Review (IPR) practice, McKool Smith